Edwards Lifesciences (EW) Numbers Trimmed at Jeffereis on Earlier CoreValve Approval
Tweet Send to a Friend
Jefferies analsyt Raj Denhoy trimmed estimates and its price target on Buy-rated Edwards Lifesciences (NYSE: EW) from $85 to $80 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
